NYSE:LLYPharmaceuticals
Eli Lilly (LLY) Valuation Check As Foundayo Oral GLP 1 Approval Lifts Obesity Growth Story
Eli Lilly (LLY) has surged back into the spotlight after the FDA approved Foundayo, a once daily oral GLP 1 pill for obesity that expands the company’s weight loss portfolio beyond injectables.
See our latest analysis for Eli Lilly.
The FDA approval of Foundayo comes after an already active period for Eli Lilly, with recent acquisitions in neuroscience and new data across dermatology and psoriatic arthritis. Over the same time, the share price has seen a 30 day return of 7.16% and a 90 day...